Epigenetic analysis of the Notch superfamily in high-grade serous ovarian cancer.
暂无分享,去创建一个
Jie Huang | Wei Hu | Anil K Sood | Keith A Baggerly | Cristina Ivan | Robert L Coleman | Gabriel Lopez-Berestein | K. Baggerly | A. Sood | C. Ivan | Jie Huang | Wei Hu | R. Coleman | G. Lopez-Berestein | J. Bottsford-Miller | A. Nick | Behrouz Zand | Heather J Dalton | Alpa M Nick | H. Dalton | Justin Bottsford-Miller | Tao Liu | Tao Liu | B. Zand
[1] Y. Tsao,et al. Peroxisome proliferator–activated receptor-γ agonists cause growth arrest and apoptosis in human ovarian carcinoma cell lines , 2006, International Journal of Gynecologic Cancer.
[2] B. Spiegelman,et al. Loss-of-function mutations in PPAR gamma associated with human colon cancer. , 1999, Molecular cell.
[3] B. Spiegelman,et al. Loss-of-Function Mutations in PPARγ Associated with Human Colon Cancer , 1999 .
[4] A. Evans,et al. miRNA profiling in metastatic renal cell carcinoma reveals a tumour-suppressor effect for miR-215 , 2011, British Journal of Cancer.
[5] Benjamin J. Raphael,et al. Integrated Genomic Analyses of Ovarian Carcinoma , 2011, Nature.
[6] X. Zhong,et al. Epigenetics of ovarian cancer: from the lab to the clinic. , 2010, Gynecologic oncology.
[7] A. Ciccodicola,et al. A Novel Peroxisome Proliferator-activated Receptor γ Isoform with Dominant Negative Activity Generated by Alternative Splicing* , 2005, Journal of Biological Chemistry.
[8] A. Sood,et al. Microenvironment and Pathogenesis of Epithelial Ovarian Cancer , 2010, Hormones & cancer.
[9] D. Ma,et al. Notch-1 regulates Akt signaling pathway and the expression of cell cycle regulatory proteins cyclin D1, CDK2 and p21 in T-ALL cell lines. , 2009, Leukemia research.
[10] P. V. van Diest,et al. Epigenetics in ovarian cancer. , 2012, Methods in molecular biology.
[11] Jianfang Li,et al. Down‐regulated miR‐625 suppresses invasion and metastasis of gastric cancer by targeting ILK , 2012, FEBS letters.
[12] D. Heo,et al. PPARγ ligands induce growth inhibition and apoptosis through p63 and p73 in human ovarian cancer cells. , 2011, Biochemical and biophysical research communications.
[13] S. Winandy,et al. Ikaros Regulates Notch Target Gene Expression in Developing Thymocytes1 , 2008, The Journal of Immunology.
[14] B. Davidson,et al. Expression of the peroxisome proliferator–activated receptors–α, –β, and –γ in ovarian carcinoma effusions is associated with poor chemoresponse and shorter survival , 2009 .
[15] R. Ozols,et al. Reclassification of serous ovarian carcinoma by a 2‐tier system , 2012, Cancer.
[16] C. Croce,et al. MicroRNA signatures in human ovarian cancer. , 2007, Cancer research.
[17] J. Dering,et al. Cyclin D1 is a direct target of JAG1-mediated Notch signaling in breast cancer , 2010, Breast Cancer Research and Treatment.
[18] Béatrice Desvergne,et al. Peroxisome-proliferator-activated receptors and cancers: complex stories , 2004, Nature Reviews Cancer.
[19] X. Yang,et al. Jagged‐1‐mediated activation of notch signalling induces adipogenesis of adipose‐derived stem cells , 2012, Cell proliferation.
[20] Shuang-Di Li,et al. The role of microRNAs in ovarian cancer initiation and progression , 2010, Journal of cellular and molecular medicine.
[21] Kenneth Shroyer,et al. Prognostic significance of miR-215 in colon cancer. , 2011, Clinical colorectal cancer.
[22] Anil K Sood,et al. Early events in the pathogenesis of epithelial ovarian cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.